Monosaccharides

Sucrose-6-acetic ester is a product of the reaction between sucrose and acetic anhydride. It is a white crystalline compound that reacts with chlorinating agents to form sulfoxide compounds. Sucrose-6-acetic ester can be converted to acetylsalicylic acid, which is used to synthesize aspirin. The reaction selectivity of this process relies on the enzyme catalysis of acetylation and triphosgene as well as an acidic or basic catalyst. Acetylation is carried out in organic solvents and requires a crystallization process for purification. This product also has fatty acid properties, which are insoluble in water and other polar solvents.

Glucose 6-phosphatase substrate

Potent and specific inhibitor of α-mannosidase I. It is active against the Golgi isoform (GMI) of the enzyme and blocks carbohydrate branch elongation from immature to complex and hybrid N-glycans. Its anti-viral activity against HIV-1 is characterized by the alteration of N-glycan pattern and shift to high-mannose glycans on viral glycoprotein gp120, resulting in decreased infectivity of newly synthesized virions.

fucosylation inhibitor

2,3,5-Tri-O-benzyl-b-D-ribofuranose is a synthetic monosaccharide that is used in the synthesis of complex carbohydrates such as glycosylation and polysaccharides. One use for this chemical is to modify the sugar moiety with methyl groups, yielding 2,3,5-tri-O-methyl b-D-ribofuranose. This modification helps prevent the sugar from being metabolized by enzymes in the body. The chemical can also be fluorinated to yield 2,3,5-trifluoro b-D-ribofuranose.

Phenyl-beta-D-thioglucuronic acid is a drug that is used to treat inflammatory diseases and autoimmune diseases. It is a basic structure that has been shown to have anti-estrogenic effects in vitro, although the mechanism of action is not well understood. Phenyl-beta-D-thioglucuronic acid can be crosslinked with proteins to form a matrix for wound healing. This drug has also been shown to be a potent inhibitor of proteases, and may inhibit other enzymes such as matrix metalloproteinases and serine proteases.

Building block for polymers synthesis, ionic liquids and chiral auxiliaries

Resource for the industrial synthesis of ascorbic acid alias Vitamin C

2,3,4,6-Tetra-O-benzyl-D-glucopyranose is a selectively protected intermediate, where the anomeric 1-O-hydroxyl group is free. This hemiacetal has been used successfully as an intermediate for glucosylation couplings, where it was converted into 2,3,4,6-tetra-O-benzyl-D-glucopyranose trichloroacetimidate using trichloroacetonitrile in the presence of a base such as potassium carbonate and DBU. Importantly, this imidate donor with no neighbouring participating groups is commonly used for the selective formation of α-glucosides. 2,3,4,6-tetra-O-benzyl-D-glucopyranose can also be oxidized to the lactone, or reduced to give the open chain form. Additionally, 2,3,4,6-tetra-O-benzyl-D-glucopyranose can be used for the preparation of glucono-1,5-lactone hydrazine, which was used, in-turn, to form a glucosylidene-spirocyclopropane.

Leucine-​derived gamma-hydroxynitrile glucoside

Glucal is a carbohydrate that is used as a synthon in organic synthesis. It has been shown to be anomeric and can be synthesized by acetylation of the corresponding aldose, or by the glycosidic bond reaction with borohydride reduction. Glucal is not stable at high pH and can undergo ring-opening reactions with nucleophiles such as sodium borohydride. Glucal also reacts with glycoconjugates to form new molecules, which are called glycosidic products.

Isosorbide dinitrate is used to treat chronic bronchitis and congestive heart failure. It dilates blood vessels, allowing more oxygen-rich blood to reach the heart. Isosorbide dinitrate is also used to relieve chest pain (angina) and reduce complications after a heart attack. Isosorbide dinitrate is a prodrug that is converted in vivo to its active form, isosorbide mononitrate, by the enzyme nitric oxide synthase in response to hypoxia. In addition, it has been shown that this drug reduces levels of low-density lipoprotein cholesterol (LDL-C) and may be useful for the treatment of high cholesterol.
The mechanism of action for reducing LDL-C levels is not known but may be due to increased clearance of LDL-C from plasma or decreased production of very low density lipoproteins (VLDL). This medication does not affect triglycerides or high density lip

1,3,5-Tri-O-benzoyl-a-D-ribofuranose is a modified carbohydrate. It is synthesized by the methylation of 1,3,5-tri-O-benzoyl-a-D-arabinopyranose followed by glycosylation with 3,6-dideoxyhexose. This compound has been used as a substrate in enzymatic studies to investigate the modification of carbohydrates by glycosylation and methylation and can be used for the synthesis of other saccharides.

2,3,4,6-Tetra-O-benzyl-D-glucopyranose is a selectively protected intermediate, where the anomeric 1-O-hydroxyl group is free. This hemiacetal has been used successfully as an intermediate for glucosylation couplings, where it was converted into 2,3,4,6-tetra-O-benzyl-D-glucopyranose trichloroacetimidate using trichloroacetonitrile in the presence of a base such as potassium carbonate and DBU. Importantly, this imidate donor with no neighbouring participating groups is commonly used for the selective formation of α-glucosides. 2,3,4,6-tetra-O-benzyl-D-glucopyranose can also be oxidized to the lactone, or reduced to give the open chain form. Additionally, 2,3,4,6-tetra-O-benzyl-D-glucopyranose can be used for the preparation of glucono-1,5-lactone hydrazine, which was used, in-turn, to form a glucosylidene-spirocyclopropane.

Ethyl 2,3,4-tri-O-benzyl-L-thiofucopyranoside is a glycosylation agent that is used in the synthesis of complex carbohydrates. It can also be used in the methylation and click modification of saccharides. Ethyl 2,3,4-tri-O-benzyl-L-thiofucopyranoside has been shown to have a high purity and can be custom synthesized to fit the needs of the customer. This product has a CAS number of 169532-17-6 and it is available in both monosaccharides and oligosaccharides.

1,5-Anhydro-2,3,4-tri-O-benzoyl-D-threo-pent-1-enitol is a high purity compound that is synthesized from D-threo pent 1 enitol. It is a sugar that belongs to the category of complex carbohydrates. This product can be custom synthesized and modified according to customer requirements.

methyl ether of glucose with the anomeric position free.